New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2014
09:34 EDTADMP, GSK, MMMAdamis completes asset acquisition from 3M Company
Adamis Pharmaceuticals (ADMP) announced that at a closing held on December 27, 2013, it made a final payment of $7M to fully acquire from 3M Company (MMM) and 3M Innovative Properties certain intellectual property and assets relating to 3M's Taper Dry Powder Inhaler technology under development for the treatment of asthma and chronic obstructive pulmonary disease. Adamis intends to utilize the assets initially to undertake efforts to develop a dry powder inhaler device for the treatment of asthma and COPD to deliver the same active ingredients as GlaxoSmithKline's (GSK) Advair Diskus. The intellectual property includes patents, patent applications and other intellectual property relating to the Taper assets.
News For ADMP;MMM;GSK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 18, 2014
09:21 EDTGSKOn The Fly: Pre-market Movers
Subscribe for More Information
07:15 EDTGSKAgenus reports GSK ZOE-50 Phase 3 study met primary endpoint
Subscribe for More Information
December 17, 2014
08:42 EDTMMM3M Company price target raised to $190 from $164 at BofA/Merrill
BofA/Merrill raised 3M Company price target to $190 following the better than expected dividend raise, rising margins, and incremental M&A in 2015-16. Shares are Buy rated.
December 16, 2014
08:52 EDTMMM3M Company says on track to deliver 2013-2017 financial objectives
Says will increase R&D investment, productivity. Says healthcare business is fastest-growing business unit. Comments taken from 3M Company's 2015 Outlook Meeting.
07:39 EDTMMM3M Company says adjusting 2013-2017 share buyback plan to $20B-$22B
Subscribe for More Information
06:10 EDTMMM3M Company raises Q1 dividend by 20% to $1.03 per share
The board of 3M declared a dividend on the companyís common stock of $1.03 per share for the Q1, a 20% increase over the quarterly dividend paid in 2014. The dividend is payable Mar. 12, 2015, to shareholders of record at the close of business on Feb. 13, 2015.
06:08 EDTMMM3M Company backs long-term EPS objective of up 9%-11% per year
Subscribe for More Information
06:06 EDTMMM3M Company sees FY15 EPS $8.00-$8.30, consensus $8.20
Subscribe for More Information
December 15, 2014
08:31 EDTMMM3M Company to sell Static Control business to Desco Industries
3M announced that it has signed an agreement with Desco Industries for Desco to purchase the assets of 3Mís global Static Control business. 3M's Static Control business is a provider of products and solutions that help prevent, detect, and protect against Electrostatic Discharge events. The transaction is expected to close during the first quarter of 2015 after the successful completion of Descoís financing and is subject to customary closing conditions. Terms of the transaction were not disclosed. 3Mís Static Control business has annual global sales of about $45M. The business employs approximately 150 people worldwide, with manufacturing operations in Sanford, N.C. Substantially all of these employees are expected to transfer to Desco.
December 11, 2014
08:29 EDTMMM3M Company December volatility elevated into 2015 Outlook Meeting
3M Company December call option implied volatility is at 22, January and April is at 17; compared to its 26-week average of 17 according to Track Data, suggesting large near term price movement into its 2015 Outlook Meeting on December 16.
06:55 EDTMMM3M Company to host 2015 outlook meeting
Subscribe for More Information
December 10, 2014
09:02 EDTMMM3M Company, Whitepeaks Dental Solutions settle dental ceramics coloring suit
Subscribe for More Information
December 9, 2014
10:23 EDTGSKOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:10 EDTGSKARIAD takeover rumors rekindled, Independent says
Subscribe for More Information
07:44 EDTGSKAmerican Association for Cancer Research to hold a symposium
Subscribe for More Information
05:37 EDTGSKGlaxoSmithKline downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill downgraded GlaxoSmithKline to Underperform citing a lack of pipeline catalysts and its belief the European pharma sector is close to fair value.
December 8, 2014
13:32 EDTGSKEpizyme announces results for PRMT5 inhibitor
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use